SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-23-011878
Filing Date
2023-05-01
Accepted
2023-05-01 16:08:41
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 sabs20230424_s3.htm S-3 263222
2 EXHIBIT 4.2 ex_510888.htm EX-4.2 57221
3 EXHIBIT 5.1 ex_508480.htm EX-5.1 10762
4 EXHIBIT 23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex_508828.htm EX-23.1 2167
5 EXHIBIT FILING FEES ex_508042.htm EX-FILING FEES 25783
6 dentons01.jpg GRAPHIC 3200
  Complete submission text file 0001437749-23-011878.txt   364763
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-271543 | Film No.: 23873662
SIC: 2836 Biological Products, (No Diagnostic Substances)